GE Healthcare (A Subsidiary of General Electric), Medtronic and Abbott are Dominating the U.S.Telestroke Market in 2020

U.S. Telestroke Market is expected to grow with the CAGR of 19.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @

U.S. telestroke market is a highly consolidated market, which includes number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in the U.S. telestroke market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, in November 2020, TeleSpecialists launched telestroke services for 200 hospitals. Within just seven years company moved from 100 to 200. This will help the company to increase its market presence in the U.S.

GE Healthcare (a subsidiary of General Electric) is the dominating player in the U.S. telestroke market. The other key players existing in the market includes Abbott, VeeMed, swyMe, TeleSpecialists, American Well, InTouch Technologies, Inc. (a subsidiary of Teladoc Health, Inc.), iSchemaView, Inc., The General Hospital Corporation, Brigham and Women's Hospital, Providence Health & Services, Medical University of South Carolina, Lakewood Health System, Nebraska Medicine, CentraCare, Mayo Foundation for Medical Education and Research (MFMER), Rush Medical University Center, Penn Medicine, UCLA Health and Medtronic among others.

 U.S. Telestroke Market GE Healthcare (A Subsidiary of General Electric)

GE Healthcare (a subsidiary of General Electric) is headquartered in Illinois, U.S. The company is engaged in providing various technological and digital solutions through applications, services and other devices to position themselves as a global leader. the company offers wide range of products categories such as breast health, labor & delivery, outpatient solutions, cardiology solutions, electrophysiology, federal health solutions, hybrid OR, neurology, oncology solutions, orthopedics and stroke solutions in which stroke solutions is market focused category.

  • In December 2019, GE Healthcare (a subsidiary of General Electric) announced partnership with MaxQ AI, a leader in medical AI diagnostics. It has helped the company to cater large number of customers as well as increase its revenue.

The company has wide global presence across Europe, Asia-Pacific, MEA, Americas with its various subsidiaries such as Hyclone Laboratories Inc (U.S.), GE Healthcare’s eMedia Studios and Services (U.S.) and Dharmacon (U.S.) among others.


Medtronic is headquartered in Minneapolis, U.S. and was founded in 1950. The company offers wide range of products for both patients and healthcare professionals and aims in transforming the entire healthcare sector. The company operates in cardiac & vascular group, minimally invasive therapies group, restorative therapies group and diabetes group segments out of which cardiac & vascular group is market focused segment. The company offers product categories which are advanced surgical technology, cardiac rhythm, cardiovascular, diabetes, digestive & gastrointestinal, ear, nose & throat, general surgery, gynecological, neurological, oral maxillofacial & dental, patient monitoring, renal care, respiratory, spinal & orthopaedic, surgical navigation & imaging and urological out of which patient monitoring is market focused category.

  • In September 2020, Medtronic was recognized by Forbes and have been included in the 2020 ‘Change the World’ list owing to their support during COVID 19 by allowing other companies to leverage their design to make design specifications without copyright royalties. This has boosted the company’ brand value.

The company has wide global presence across Americas, Asia, Europe and generates revenue from subsidiaries such as Avenu Medical, Inc. (U.S.), Given Imaging (Israel), Medtronic of Canada Ltd (Canada), HeartWare International Inc. (U.S.) and Valleylab Inc (U.S.) among others.


Abbott is headquartered in Illinois, U.S. and was founded in 1888. The company offers various kinds of products for various types of diseases for both consumers and healthcare professionals. The company operates in established pharmaceutical products, diagnostic products, nutritional products and medical devices segments out of which medical devices are market focused segment. The company provides cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicines out of which cardiovascular are market focused product category.

  • In September 2019, Abbott launched Merlin 10.0, which is their remote monitoring solution for patients suffering from heart failures. It is based on CardioMEMS HF sensor system that allows physicians to send their patients custom notifications. It has allowed the company to provide more personalized service to its customers which have increased their brand value.

The company has presence across the globe in North America, South America, Asia Pacific, Europe, and Africa. In addition to it, the company also generates its revenue from the various subsidiary companies such as Alere Inc. (U.S.), Panbio Ltd (Australia), Abbott India Ltd (India), Abbott Healthcare Pvt Ltd (India) and Abbott Japan Co., Ltd. (Japan) among others.